Drug Shortage Report for MYLAN-ALMOTRIPTAN
| Report ID | 273789 |
| Drug Identification Number | 02398443 |
| Brand name | MYLAN-ALMOTRIPTAN |
| Common or Proper name | ALMOTRIPTAN |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALMOTRIPTAN |
| Strength(s) | 12.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 6BL |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-01-16 |
| Actual start date | |
| Estimated end date | 2026-01-27 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-12-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-08 | French | Compare |
| v1 | 2025-12-08 | English | Compare |
Showing 1 to 2 of 2